AGS-004

· Agenus, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AGS-004, covering 2009-01-29 to 2017-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004 [Phase 1]